ACE inhibitors: back to prime time?

Heart. 2007 Sep;93(9):1015-6. doi: 10.1136/hrt.2006.108100.

Abstract

See articles on pages 1026 and 1081

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / economics
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Cardiovascular Agents / economics
  • Cardiovascular Agents / therapeutic use*
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / economics
  • Cost-Benefit Analysis
  • Evidence-Based Medicine
  • Humans
  • Randomized Controlled Trials as Topic

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Cardiovascular Agents